Therapeutic HIV vaccine trial launched in Canada.

Abstract

The first-ever clinical trial of a therapeutic HIV vaccine in Canada is currently underway. The trial is being run by the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) in cooperation with Aventis Pasteur, of France, and the Immune Response Corporation (IRC), of the United States.